Novel human microbe-disease associations inference based on network consistency projection

Increasing evidence shows that microbes are closely related to various human diseases. Obtaining a comprehensive and detailed understanding of the relationships between microbes and diseases would not only be beneficial to disease prevention, diagnosis and prognosis, but also would lead to the discovery of new drugs. However, because of a lack of data, little effort has been made to predict novel microbe-disease associations. To date, few methods have been proposed to solve the problem. In this study, we developed a new computational model based on network consistency projection to infer novel human microbe-disease associations (NCPHMDA) by integrating Gaussian interaction profile kernel similarity of microbes and diseases, and symptom-based disease similarity. NCPHMDA is a non-parametric and global network based model that combines microbe space projection and disease space projection to achieve the final prediction. Experimental results demonstrated that the integrated space projection of microbes and diseases, and symptom-based disease similarity played roles in the model performance. Cross validation frameworks and case studies further illustrated the superior predictive performance over other methods.

[1]  Lin Liu,et al.  Inferring novel lncRNA-disease associations based on a random walk model of a lncRNA functional similarity network. , 2014, Molecular bioSystems.

[2]  D. Bessesen,et al.  Human gut microbes associated with obesity , 2007 .

[3]  B. Birren,et al.  The “Most Wanted” Taxa from the Human Microbiome for Whole Genome Sequencing , 2012, PloS one.

[4]  Fuhao Zou,et al.  Type 2 Diabetes Biomarkers of Human Gut Microbiota Selected via Iterative Sure Independent Screening Method , 2015, PloS one.

[5]  Ye Ai-lin Clinical features of type 2 diabetes patients complicated with urinary tract infections , 2013 .

[6]  P. Adhikari,et al.  Asymptomatic Bacteriuria with Escherichia coli in Type 2 Diabetic Patients: An Unresolved Riddle , 2016 .

[7]  James Versalovic,et al.  Human microbiome in health and disease. , 2012, Annual review of pathology.

[8]  Brian Goodman,et al.  The microbiome and cancer , 2018, The Journal of pathology.

[9]  Joseph R Arron,et al.  The airway microbiome in patients with severe asthma: Associations with disease features and severity. , 2015, The Journal of allergy and clinical immunology.

[10]  A Quintero,et al.  Presencia de Porphyromonas gingivalis, Tannerella forsythia, Treponema denticola y Aggregatibacter actinomycetemcomitans en el biofilm subgingival de pacientes diabéticos tipo 2: estudio transversal , 2011 .

[11]  Shyam Mohapatra,et al.  Microbes and asthma: the missing cellular and molecular links , 2012, Current opinion in pulmonary medicine.

[12]  Jason L Salemi,et al.  Clostridium difficile infection in patients hospitalized with type 2 diabetes mellitus and its impact on morbidity, mortality, and the costs of inpatient care. , 2016, Diabetes research and clinical practice.

[13]  Aftab Ahmed Soomro,et al.  Type 2 diabetes mellitus: A risk factor for Helicobacter pylori infection: A hospital based case-control study , 2010, International journal of diabetes in developing countries.

[14]  P. Turnbaugh,et al.  Microbial ecology: Human gut microbes associated with obesity , 2006, Nature.

[15]  Lu Wang,et al.  The NIH Human Microbiome Project. , 2009, Genome research.

[16]  Patrick M Schlievert,et al.  Does Staphylococcus aureus have a role in the development of Type 2 diabetes mellitus? , 2015, Future microbiology.

[17]  D. Savage Microbial ecology of the gastrointestinal tract. , 1977, Annual review of microbiology.

[18]  Michael Inouye,et al.  Vitamin D over the first decade and susceptibility to childhood allergy and asthma , 2017, The Journal of allergy and clinical immunology.

[19]  E. Mardis,et al.  An obesity-associated gut microbiome with increased capacity for energy harvest , 2006, Nature.

[20]  Zhu-Hong You,et al.  PBHMDA: Path-Based Human Microbe-Disease Association Prediction , 2017, Front. Microbiol..

[21]  V. Debari,et al.  Diabetes mellitus as a risk factor for recurrence of Clostridium difficile infection in the acute care hospital setting. , 2011, American journal of infection control.

[22]  Jennifer C. Drew,et al.  Toward defining the autoimmune microbiome for type 1 diabetes , 2011, The ISME Journal.

[23]  Gérard Eberl,et al.  Lymphoid tissue genesis induced by commensals through NOD1 regulates intestinal homeostasis , 2008, Nature.

[24]  Zhu-Hong You,et al.  A novel approach based on KATZ measure to predict associations of human microbiota with non‐infectious diseases , 2016, Bioinform..

[25]  Mario Castro,et al.  Features of the bronchial bacterial microbiome associated with atopy, asthma, and responsiveness to inhaled corticosteroid treatment , 2017, Journal of Allergy and Clinical Immunology.

[26]  Sejal Saglani,et al.  Lung microbiota promotes tolerance to allergens in neonates via PD-L1 , 2014, Nature Medicine.

[27]  Daniel B. DiGiulio,et al.  Development of the Human Infant Intestinal Microbiota , 2007, PLoS biology.

[28]  M Ojima,et al.  Relationship of Porphyromonas gingivalis with glycemic level in patients with type 2 diabetes following periodontal treatment. , 2008, Oral microbiology and immunology.

[29]  Sang-Gue Park,et al.  Analysis of Oropharyngeal Microbiota between the Patients with Bronchial Asthma and the Non-Asthmatic Persons , 2013 .

[30]  M. Ege,et al.  The Hygiene Hypothesis in the Age of the Microbiome. , 2017, Annals of the American Thoracic Society.

[31]  D. G. Pinheiro,et al.  Detection of Increased Plasma Interleukin-6 Levels and Prevalence of Prevotella copri and Bacteroides vulgatus in the Feces of Type 2 Diabetes Patients , 2017, Front. Immunol..

[32]  José Luís Oliveira,et al.  Computational methodology for predicting the landscape of the human-microbial interactome region level influence , 2015, J. Bioinform. Comput. Biol..

[33]  De-Shuang Huang,et al.  Novel human microbe-disease association prediction using network consistency projection , 2017, BMC Bioinformatics.

[34]  Keqin Li,et al.  Network Consistency Projection for Human miRNA-Disease Associations Inference , 2016, Scientific Reports.

[35]  F. Bäckhed,et al.  The gut microbiota — masters of host development and physiology , 2013, Nature Reviews Microbiology.

[36]  Katherine H. Huang,et al.  Structure, Function and Diversity of the Healthy Human Microbiome , 2012, Nature.

[37]  Xianjun Shen,et al.  Prioritizing disease-causing microbes based on random walking on the heterogeneous network. , 2017, Methods.

[38]  Abdulbari Bener,et al.  Association between type 2 diabetes mellitus and Helicobacter pylori infection. , 2007, The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology.

[39]  Sang-Gue Park,et al.  Microbial Communities in the Upper Respiratory Tract of Patients with Asthma and Chronic Obstructive Pulmonary Disease , 2014, PloS one.

[40]  A. Barabasi,et al.  Human symptoms–disease network , 2014, Nature Communications.

[41]  Q. Zou,et al.  Prediction of MicroRNA-Disease Associations Based on Social Network Analysis Methods , 2015, BioMed research international.

[42]  Borja Sánchez,et al.  Allergic Patients with Long-Term Asthma Display Low Levels of Bifidobacterium adolescentis , 2016, PloS one.

[43]  Piotr Gutkowski,et al.  Effect of orally administered probiotic strains Lactobacillus and Bifidobacterium in children with atopic asthma , 2011 .

[44]  Martyn Shuttleworth Estudio transversal , 2014 .

[45]  E. Purdom,et al.  Diversity of the Human Intestinal Microbial Flora , 2005, Science.

[46]  A. Tamer,et al.  Staphylococcus aureus nasal carriage and associated factors in type 2 diabetic patients. , 2006, Japanese journal of infectious diseases.

[47]  B T Yang,et al.  [Porphyromonas gingivalis FimA genotype distribution among periodontitis patients with type 2 diabetes]. , 2016, Zhonghua kou qiang yi xue za zhi = Zhonghua kouqiang yixue zazhi = Chinese journal of stomatology.

[48]  Herman Goossens,et al.  Early intestinal Bacteroides fragilis colonisation and development of asthma , 2008, BMC pulmonary medicine.

[49]  Sanne Abeln,et al.  metaModules identifies key functional subnetworks in microbiome-related disease , 2016, Bioinform..

[50]  J. Kreth,et al.  Streptococcal Antagonism in Oral Biofilms: Streptococcus sanguinis and Streptococcus gordonii Interference with Streptococcus mutans , 2008, Journal of bacteriology.

[51]  Ting-Feng Wu,et al.  Helicobacter pylori Infection Is Associated with Type 2 Diabetes, Not Type 1 Diabetes: An Updated Meta-Analysis , 2017, Gastroenterology research and practice.

[52]  S A Hassan,et al.  Hospital-acquired Clostridium difficile infection among patients with type 2 diabetes mellitus in acute medical wards. , 2013, The journal of the Royal College of Physicians of Edinburgh.

[53]  F E Dewhirst,et al.  Microbiological diversity of generalized aggressive periodontitis by 16S rRNA clonal analysis. , 2008, Oral microbiology and immunology.

[54]  GottschalkFraence,et al.  Staphylococcus aureus Infections in German Patients with Type 2 Diabetes Mellitus after Orthopedic Surgery: Incidence, Risk Factors, and Clinical and Health-Economic Outcomes. , 2017 .

[55]  S. Mazmanian,et al.  Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota , 2010, Proceedings of the National Academy of Sciences.

[56]  J. Lederberg,et al.  `Ome Sweet `Omics--A Genealogical Treasury of Words , 2001 .

[57]  Tobias Kollmann,et al.  Early infancy microbial and metabolic alterations affect risk of childhood asthma , 2015, Science Translational Medicine.